B ALL
Clinical trials for B ALL explained in plain language.
Never miss a new study
Get alerted when new B ALL trials appear
Sign up with your email to follow new studies for B ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New engineered cell therapy tested in kids with Tough-to-Treat cancers
Disease control CompletedThis study tested a new type of personalized cell therapy for children and young adults whose leukemia or lymphoma had come back or did not respond to standard treatments. Researchers collected a patient's own immune cells, genetically modified them in a lab to recognize a protei…
Matched conditions: B ALL
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Early trial tests new combo for tough blood cancers
Disease control CompletedThis study tested a new combination of two drugs, acalabrutinib and ACP-319, for people with B-cell cancers like non-Hodgkin's lymphoma and multiple myeloma. The main goals were to find the safest dose and see if the treatment was effective at controlling the disease. It involved…
Matched conditions: B ALL
Phase: PHASE1, PHASE2 • Sponsor: Acerta Pharma BV • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
New immune cell therapy tested for leukemia patients out of options
Disease control CompletedThis early-stage study tested a new CAR-T cell therapy called ThisCART19A in 10 adults with B-cell acute lymphoblastic leukemia (B-ALL) that had returned or stopped responding to other treatments. The main goal was to check the safety of the treatment and see how the body handles…
Matched conditions: B ALL
Phase: PHASE1 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC